Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs133.34 M151.46 M177.28 M199.35 M168.36 M117.05 M121.06 MRecherche et développement———————Résultat d'exploitation462.51 M613.99 M638.53 M278.66 M673.79 M-1.65 B-1.32 BTotal des produits hors exploitation421.32 M259.48 M-331.76 M-195.4 M-53.12 M-56.34 M-10.93 MCharges d'intérêts, nettes des intérêts capitalisés171.61 M142.16 M94.2 M74.2 M185.84 M226.7 M240.41 MRésultat hors exploitation, hors charges d'intérêts249.71 M117.31 M-425.96 M-269.6 M-238.96 M-283.04 M-251.34 MRevenus/dépenses exceptionnels———————Résultat avant impôts1.01 B1.1 B1.35 B1.13 B1.53 B-653.42 M-680.93 MPart des actionnaires dans le résultat8.15 M12.26 M645 K980 K7.06 M-9.63 M-9.27 MImpôts———————Intérêts ne donnant pas le contrôle / intérêts minoritaires56.21 M83.03 M149.04 M177.35 M187.78 M212.84 M201.97 MAutres produits/charges après impôts———————Résultat net avant activités abandonnées770.96 M571.25 M521.66 M103.64 M322.95 M-1.43 B-1.06 BActivités abandonnées———————Résultat net770.96 M571.25 M521.66 M103.64 M322.95 M-1.43 B-1.06 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires760.79 M563.4 M513.27 M92.44 M309.56 M-1.44 B-1.07 BBénéfice par action de base (BPA de base)6.033.833.180.541.8-8.44-6.27Bénéfice par action dilué (BPA dilué)6.013.823.180.541.8-8.44-6.27Nombre moyen d'actions de base en circulation126.11 M146.92 M161.66 M170.91 M172.07 M170.31 M—Nombre d'actions en circulation après dilution126.49 M147.46 M161.66 M170.91 M172.07 M170.31 M—EBITDA250.55 M265.38 M477.83 M215.07 M445.92 M-1.77 B-1.81 BEBIT243.61 M255.98 M463.9 M198.37 M427.48 M-1.79 B-1.83 BCoût des ventes530.22 M623.55 M783.15 M859.18 M908.59 M922.61 M920.35 MAutres coûts des ventes530.22 M623.55 M783.15 M859.18 M909.26 M922.61 M920.35 MAmortissements (flux de trésorerie)6.94 M9.4 M13.93 M16.69 M18.44 M19.63 M19.34 M
Alexandria Real Estate Equities, Inc. Common Stock
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area.
The company is dependent on the life sciences industry and funding for research by the United States Government.
The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms.
The company is named after Alexandria, Egypt because of that city's connection to science.